SCHEMBL9033166

SCHEMBL9033166

CCCCc1nn(-c2ccccc2)c(=O)[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.48
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
CNR2 P34972 2/20 0.43
CNR1 P21554 1/20 0.43
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALOX5 P09917 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
AGTR1 P30556 1/20 0.38
AGTR2 P50052 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29001509 0.91 HCAR1 (0.42) CNR2CNR1KDM4EHSD17B10LMNA
SCHEMBL29001531 0.85 TSHR (0.42) PARP1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL29001505 0.85 CTSK (0.43) LMNAMAPTL3MBTL1RAB9AALDH1A1
SCHEMBL29001520 0.85 TSHR (0.40) PARP1SMN1; SMN2LMNAMAPTNPSR1
SCHEMBL10274594 0.84 ADORA3 (0.47) KDM4ESMN1; SMN2HSD17B10L3MBTL1ALDH1A1
SCHEMBL9143800 0.84 NPC1 (0.50) SMN1; SMN2L3MBTL1RAB9A
SCHEMBL29001519 0.81 PARP1 (0.42) PARP1PDE4APDE4BPDE4CPDE4D
SCHEMBL9031575 0.80 PARP1 (0.41) PARP1PDE4APDE4BPDE4CPDE4D
SCHEMBL9141986 0.80 ABHD16A (0.46) PDE4APDE4BPDE4CPDE4DCNR1
SCHEMBL11178637 0.79 NPC1 (0.50) PARP1KDM4EHSD17B10NPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115745983-A Angiotensin and endothelin receptor antagonist and application thereof 深圳信立泰药业股份有限公司 2023-03-07 CN disclosed
EP-0412594-B1 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO INC (US) 1996-01-03 EP disclosed
US-5411980-A Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO., INC. (US) 1995-05-02 US disclosed
EP-0586513-A1 ACIDIC ARALKYL TRIAZOLE DERIVATIVES ACTIVE AS ANGIOTENSIN II ANTAGONISTS MERCK & CO. INC. (US) 1994-03-16 EP disclosed
US-5281614-A Hypotensive agents, glaucoma or angiotensin antagonists MERCK & CO., INC. (US) 1994-01-25 US disclosed
WO-1992020662-A1 ACIDIC ARALKYL TRIAZOLE DERIVATIVES ACTIVE AS ANGIOTENSIN II ANTAGONISTS MERCK & CO., INC. (US) 1992-11-26 WO disclosed
EP-0412594-A2 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO. INC. (US) 1991-02-13 EP disclosed